23 related articles for article (PubMed ID: 7542899)
1. The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats.
Bagi C; van der Meulen M; Brommage R; Rosen D; Sommer A
Bone; 1995 May; 16(5):559-65. PubMed ID: 7544602
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck.
Bagi CM; DeLeon E; Brommage R; Rosen D; Sommer A
Calcif Tissue Int; 1995 Jul; 57(1):40-6. PubMed ID: 7545533
[TBL] [Abstract][Full Text] [Related]
3. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
[TBL] [Abstract][Full Text] [Related]
4. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.
Bagi CM; Brommage R; Deleon L; Adams S; Rosen D; Sommer A
J Bone Miner Res; 1994 Aug; 9(8):1301-12. PubMed ID: 7526611
[TBL] [Abstract][Full Text] [Related]
5. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
Bauss F; Lang K; Dony C; Kling L
Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
[TBL] [Abstract][Full Text] [Related]
6. Potential role of rhIGF-I/IGFBP-3 in maintaining skeletal mass in space.
Tanaka H; Moriwake T; Matsuoka Y; Nakamura T; Seino Y
Bone; 1998 May; 22(5 Suppl):145S-147S. PubMed ID: 9600772
[TBL] [Abstract][Full Text] [Related]
7. Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.
Williams RM; McDonald A; O'Savage M; Dunger DB
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):311-24. PubMed ID: 18363546
[TBL] [Abstract][Full Text] [Related]
8. Potential applications for rhIGF-I: Bone disease and IGFI.
Bahamonde M; Misra M
Growth Horm IGF Res; 2020 Jun; 52():101317. PubMed ID: 32252004
[TBL] [Abstract][Full Text] [Related]
9. The prevention or treatment of age-related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF-I or rhTGF beta): a perspective.
Boonen S; Broos P; Dequeker J; Bouillon R
J Intern Med; 1997 Oct; 242(4):285-90. PubMed ID: 9366806
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
